Neurobiological Correlates of Antidepressant Response After Duloxetine Hydrochloride Treatment in Subjects With Major Depressive Disorder
Phase of Trial: Phase IV
Latest Information Update: 15 Nov 2014
At a glance
- Drugs Duloxetine (Primary)
- Indications Major depressive disorder
- Focus Biomarker; Pharmacodynamics
- Acronyms HMGO
- Sponsors Eli Lilly
- 10 Jun 2017 Biomarkers information updated
- 01 Mar 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.